TCI Wealth Advisors, Inc. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 300 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.62 and the average weighting 0.4%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$2,869
+10.1%
390.0%0.00%
Q4 2022$2,605
-13.2%
390.0%0.00%
Q3 2022$3,0000.0%390.0%0.00%
Q2 2022$3,000
-57.1%
39
-9.3%
0.00%
-100.0%
Q4 2021$7,000
+40.0%
43
+10.3%
0.00%0.0%
Q3 2021$5,000
+25.0%
39
+34.5%
0.00%0.0%
Q2 2021$4,000
+300.0%
29
+141.7%
0.00%
Q4 2019$1,0000.0%120.0%0.00%
Q3 2019$1,000
-50.0%
12
-33.3%
0.00%
-100.0%
Q2 2019$2,0000.0%180.0%0.00%0.0%
Q1 2019$2,0000.0%180.0%0.00%0.0%
Q4 2018$2,000
-60.0%
180.0%0.00%
-50.0%
Q3 2018$5,000
+25.0%
180.0%0.00%0.0%
Q2 2018$4,000
+33.3%
180.0%0.00%
+100.0%
Q1 2018$3,000
+50.0%
180.0%0.00%0.0%
Q4 2017$2,0000.0%180.0%0.00%0.0%
Q3 2017$2,0000.0%180.0%0.00%0.0%
Q2 2017$2,0000.0%180.0%0.00%0.0%
Q1 2017$2,0000.0%180.0%0.00%0.0%
Q4 2016$2,000
-33.3%
18
-33.3%
0.00%
-50.0%
Q3 2016$3,0000.0%270.0%0.00%0.0%
Q2 2016$3,0000.0%270.0%0.00%0.0%
Q1 2016$3,000
-40.0%
27
-63.5%
0.00%
-33.3%
Q2 2014$5,0000.0%740.0%0.00%0.0%
Q1 2014$5,000
+25.0%
740.0%0.00%0.0%
Q4 2013$4,000
+33.3%
740.0%0.00%
+50.0%
Q3 2013$3,0000.0%740.0%0.00%0.0%
Q2 2013$3,000740.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
VILLERE ST DENIS J & CO LLC 518,988$80,162,0004.60%
Knott David M Jr 75,000$11,585,0003.93%
Orchard Capital Management, LLC 68,596$10,595,0003.11%
Chicago Capital, LLC 436,456$67,415,0002.51%
RICE HALL JAMES & ASSOCIATES, LLC 347,699$53,706,0001.91%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 85,990$13,282,0001.46%
Smith, Graham & Co., Investment Advisors, LP 87,392$13,499,0001.34%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 44,754$6,913,0001.12%
WOODSTOCK CORP 68,666$10,606,0001.11%
Stephens Investment Management Group LLC 411,359$63,539,0000.82%
View complete list of LIGAND PHARMACEUTICALS INC shareholders